Default company panoramic image
1a0e039a 0c2b 460d 90d4 856958094324

Hilltop BioSciences

Hilltop Bio, a veterinary biotech has developed novel therapies for inflammatory diseases such as equine asthma and canine osteoarthritis.

  • Stage Product In Market
  • Industry Biotechnology
  • Location Boston, MA, USA
  • Currency USD
  • Founded September 2018
  • Employees 4
  • Incorporation Type C-corp
  • Website hilltopbio.com

Company Summary

Veterinarians have many solutions to treat inflammatory diseases and injuries. Most of those solutions are a band-aid or management solution and not actually healing the underlying cause of the injury or disease.

Hilltop Bio provides the whole orchestra of components including exosomes, and cytokines in an easy to use shelf stable product that helps our animals heal quickly and effectively.

The company sells direct to vets in a B2B model.

Team

  • F4c79348 dd1e 4b09 8f86 57b52dded67e
    VP Sales and Distribution

    20 years experience in veterinary sales, bringing new products to market and leading large sales teams

  • C223e817 6782 4dd8 8004 2d7044c9c83e
    Chief Veterinary Officer

    Dr. Dutton is an equine sports medicine veterinarian with 20+ years experience as a practice owner and treating vet. He has researched and used a variety of regenerative therapies in many different indications and brings his experiences and expertise to Hilltop Bio.

Advisors